This site is intended for Healthcare Professionals only

Class 2 Medicines Recall: Mollipaxin 100mg capsules

Class 2 Medicines Recall: Mollipaxin 100mg capsules

Class 2 Medicines Recall: Mollipaxin 100mg capsules (one batch)

Winthrop Pharmaceuticals UK Limited (trading as Zentiva) is conducting a precautionary recall of a single batch of Mollipaxin 100 mg capsules due to a potential issue with the metal detector during manufacture of the batch (EL(18) A/01).

Update: First published.

For further information on this published alert click here.

 

Copy Link copy link button

Share:

Change privacy settings